FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and top agency official Vinay ...

Regulators have scrutinized offshore purchasing units for years due to concerns about transparency and tax avoidance. By moving Ascent back to U.S. soil, the FTC aims to bring over $750 billion in ...

This article examines the PBM-related provisions in the 2026 Consolidated Appropriations Act in the context of other federal and state efforts to regulate PBMs, then offers recommendations on ...

TrumpRx was unveiled this month as part of an effort to foster a more competitive marketplace for prescription drugs.

Lower drug prices offered through direct-to-consumer websites like TrumpRx are failing to reach patients with commercial ...

Drug pricing 2026 forces are reshaping pharmacy economics through Medicare negotiations, FTC actions, and federal pricing models.

For respondents facing novel Federal Trade Commission theories, the lesson is that early engagement—not reflexive litigation—can yield outcomes that address regulatory concerns while preserving ...

IN NOVEMBER 2025, Genoa Healthcare in Gualala, the sole pharmacy along a 60-mile stretch of Mendocino County coast, shut down ...

Americans pay more for pharmaceuticals than others around the world, and the chief executive officer of 46 Brooklyn Research believes he knows why.

Three Republican state senators intend to introduce legislation that would reform pharmacy benefit managers to “better serve ...

DOGE members say the city could make the switch in about 90 days and intend to send their recommendations to the mayor’s office in time to potentially impact next year’s budget, according to News4JAX.

State Rep. Frank Burns has asked Gov. Josh Shapiro to initiate an investigation of the pharmacy benefit management company Express Scripts for potential antitrust violations in its ...